Cannabis: Recommended CBD dosage has been reduced in the UK because of safety concerns

Cannabis: Recommended CBD dosage has been reduced in the UK because of safety concerns

Since 2018, when the British parliament passed a law legalizing CBD, the non-psychoactive ingredient of cannabis, sales of CBD-related products have skyrocketed. Nowadays, you can buy CBD oil, CBD vape pens, CBD coffee, CBD muffins to go with your CBD coffee everything. And these products are often sold with vague promises of improved health. As … Read more

Abbott CEO: Concerns About GLP-1 in Medtech Are Overblown

Senior woman using a continuous glucose monitoring device to manage type 2 diabetes. .png

There has been a lot of noise in recent weeks surrounding the GLP-1 drugs and their ripple effect on medical technology, but Abbott CEO Robert Ford says these concerns are overblown. level. In fact, Ford remained optimistic Tuesday morning when discussing the potential relationship between the GLP-1 drug and medical technology. Initially approved to treat … Read more

Pharmacies compounding Semaglutide raises concerns

Pharmacies compounding Semaglutide raises concerns

The US Food and Drug Administration (FDA) recently warned two online suppliers to stop manufacturing unapproved versions of semaglutide (marketed as Ozempic for type 2 diabetes). 2; Wegovy for obesity) and tirzepatide (Mounjaro). With ongoing shortages of these two popular drugs, compounded versions have become popular. According to the FDA, compounding pharmacies are allowed to … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

CNN — Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns among doctors that the drug will become more difficult to reach. Just like this season’s Covid-19 vaccine, the combination antiviral drug nirmatrelvir … Read more

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access | CNN

Price of Covid-19 antiviral drug Paxlovid expected to rise next year, raising concerns about access |  CNN

Stephanie Nano/AP/File Paxlovid will move from making it free to everyone through government purchases to the more traditional commercial market later this year. CNN Prices for the Covid-19 drug Paxlovid will likely rise next year for most patients as the United States continues to move out of the emergency phase of the pandemic, raising concerns … Read more